Computerized System Validation (CSV) Site Lead
CSL Behring
This listing was originally posted on CSL Behring's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moCSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
We are recruiting a Computerized System Validation (CSV) Site Lead to join our team at our manufacturing facility at 189–209 Camp Road, Broadmeadows, VIC 3047.
Job Description
CSL is seeking an experienced CSV Site Lead to own and govern Computerized System Validation (CSV) approach and strategy for site Operational Technology (OT) platforms supporting Manufacturing and QC Laboratories.
This is a senior individual contributor role with strong influence across site teams and external partners. Operating within a partner-led delivery model, the CSV Site Lead ensures OT systems remain in a validated state across their lifecycle and meet global CSV, quality, data integrity, and regulatory expectations.
You will act as the site CSV authority for OT Platforms, providing strategic direction, governance, and oversight across CSV planning, delivery, vendor QMS integration, and driving regulatory inspections and inspection readiness.
This is a Permanent full-time position.
Key Responsibilities
Qualifications & Experience
Application Period: Applications open on 16 October and close on 16 Novemmber 2026.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at CSL Behring?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Biologics
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo